In a mouse model of ROR1-positive NSCLC, after pretreatment with oxaliplatin/cyclophosphamide (Ox/Cy), CAR-T cells showed better penetration of the tumor tissue, resulting in increased chemokine release from tumor-associated macrophages. The gene discussed is ROR1; the disease is neoplasm.